Free Webinar from Industry Expert Rebecca Shafer: Reduce Workers’ Compensation Cost by Understanding and Controlling Key Cost Drivers
Date: August 21, 2012
Time: 11:00 am CST
Duration: 1 hour
Employers often think that there is nothing that they can do to control workers’ compensation costs. Many times they don’t know where to start, don’t have the resources to get the job done, don’t have the time to do it themselves or don’t have the staff to support the cost-reduction efforts.
Gould & Lamb to Host Medicare Secondary Payer Compliance Breakout at Workers’ Compensation Institute Educational Conference
The 67th Annual Workers’ Compensation Educational Conference and the 24th Annual Safety and Health Conference are just around the corner. Set for August 19 through 23, 2012 at the Orlando World Marriott, the conference will again focus on the national workers’ compensation and safety industries, serving..
Tackling the Toughest Workers Comp Claims
Published in Business Insurance, Author Mark Walls, Safety National.
One of the biggest cost drivers in Workers Compensation is seemingly “average” claims that take a turn for the worst and result in several years of medical treatment and disability. Mark Walls, vp of claims for Safety National Casualty Corp discusses the common threads of “creeping catastrophic” claims.
Worried about inappropriate opioid prescribing? Here’s your chance to do something about it.
Posted by Marianne Cloeren, MD, MPH, FACOEM – Managed Care Advisors
The organization Physicians for Responsible Opioid Prescribing (PROP) filed a petition with the FDA to change the labeling for opioid analgesics so that it does not include use for chronic non-cancer pain. They make the excellent point that research is showing lack of effectiveness and high risk.
Here is more information from the president of PROP, Dr. Andrew Kolodny about this effort:
“I’m writing in the hope that you’ll submit comments to FDA supporting the citizen petition for label changes on opioid analgesics.
As you may have heard, a couple of weeks ago PROP filed this petition with FDA. This request has received support from members of Congress, including Rep. Mary Bono Mack and Hal Rogers, so we believe that FDA is paying close attention.
Here’s the link where you can submit Comments:
http://www.regulations.gov/#!submitComment;D=FDA-2012-P-0818-0001
You can read the petition here:
http://www.citizen.org/documents/2048.pdf
And here’s a press release about the petition that was issued by Public Citizen:
http://www.citizen.org/pressroom/pressroomredirect.cfm?ID=3674
If FDA implements our request, opioid manufacturers will be prohibited from promoting long-term use of opioids for chronic non-cancer pain and the medical community will be informed that this practice has not been proven safe and effective. We believe that this will help reduce overprescribing of opioids. And since it’s overprescribing that’s harming pain patients and fueling the opioid addiction epidemic, the label change could help bring this public health crisis under control
Author Michael B. Stack, CPA, Director of Operations, Amaxx Risk Solutions, Inc. is an expert in employer communication systems and part of the Amaxx team helping companies reduce their workers compensation costs by 20% to 50%. He is a writer, speaker, and website publisher. www.reduceyourworkerscomp.com. Contact: [email protected].
WORKERS COMP MANAGEMENT MANUAL: www.WCManual.com
Do not use this information without independent verification. All state laws vary. You should consult with your insurance broker or agent about workers’ comp issues.
©2012 Amaxx Risk Solutions, Inc. All rights reserved under International Copyright Law. If you would like permission to reprint this material, contact us at: [email protected].
